<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2905A4AF-E97E-4AA4-BC57-169D322523AD"><gtr:id>2905A4AF-E97E-4AA4-BC57-169D322523AD</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Offer</gtr:surname><gtr:orcidId>0000-0002-2471-1216</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U117592730"><gtr:id>96A5481D-0D72-4A4E-B7BD-18C6B57B6C8D</gtr:id><gtr:title>Synthetic Protein Laboratory</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U117592730</gtr:grantReference><gtr:abstractText>The group is a chemical biology group working at the interface of chemistry, biology and medicine. The explosion of proteins and peptides in use as pharmaceuticals has increased the demand for pure synthetic molecules that contain no biological contaminants. Research on improving chemical synthesis gives access to new materials which incorporate non-natural tags for diagnostic and therapeutic purposes. The chemical methods developed can be exploited for the synthesis of chemically defined vaccines.</gtr:abstractText><gtr:technicalSummary>Our group is interested in bioconjugation and protein design. Principle areas of focus have been on developing new ligation chemistry and investigating possible naturally occurring roles for this chemistry.||Proteins can be chemically synthesized by a combination of optimized peptide synthesis and ligation using both synthetic peptides and peptides sourced from biological expression. Synthetic proteins may be constructed to contain multiple non-natural components, releasing the investigator from the restraint of the genetic code. These techniques give access to incorporate biophysical probes such as fluorescent residues for single molecule studies, isotope labels for NMR and to proteins with chemically defined post-translational modification. In addition it opens synthetic access to designed biomaterials modelled on simple self-assembling peptides and the re-engineering of enzyme function.||The challenge for developing novel ligation reactions is to realise a method that goes to completion in water at low concentration between equal amounts of reactants. These characteristics not only simplify synthesis, but also give the chemistry compatibility with biopolymers and allow the manipulation of proteins, even in vivo. This chemistry is not only useful to the synthesis of proteins but also for the synthesis of chemically designed vaccine candidates. The groups work here is based on the principles of peptide chemical ligation to expand synthetic access to proteins, to apply the principles of ligation to other synthetic challenges and to accelerate lead generation for high throughput screening and answer related biomedical problems.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2239589</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>11FD0463-D8A9-4495-9A43-26133F52B1D3</gtr:id><gtr:title>Presynaptic miniature GABAergic currents in developing interneurons.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76b2edf9530517bb0cb949d73719cdb3"><gtr:id>76b2edf9530517bb0cb949d73719cdb3</gtr:id><gtr:otherNames>Trigo FF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>c3nbD5pJV5G</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15806616-34B0-4C15-8DF1-B9626DE40ABE</gtr:id><gtr:title>Automated synthesis of backbone protected peptides.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc3eaf4587e2cc3efe963aa0863929c4"><gtr:id>bc3eaf4587e2cc3efe963aa0863929c4</gtr:id><gtr:otherNames>Abdel-Aal AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>545bbbfee7ce12.55833517</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2254C3B2-702B-457F-B543-0E41AC8CBB7F</gtr:id><gtr:title>Advances in Fmoc solid-phase peptide synthesis.</gtr:title><gtr:parentPublicationTitle>Journal of peptide science : an official publication of the European Peptide Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8b4d7dd2a0857aa37cda1e2dd318b50"><gtr:id>e8b4d7dd2a0857aa37cda1e2dd318b50</gtr:id><gtr:otherNames>Behrendt R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1075-2617</gtr:issn><gtr:outcomeId>574efd9a877a77.58100572</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BA7F303-B911-4C80-A6B6-68D66E3B8799</gtr:id><gtr:title>Hypoxic regulation of hand1 controls the fetal-neonatal switch in cardiac metabolism.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/daf342954ef6f15c10706d127234ee8b"><gtr:id>daf342954ef6f15c10706d127234ee8b</gtr:id><gtr:otherNames>Breckenridge RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>pm_14701_21_24086110</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30EF46F4-7CAC-4B9C-9A20-8AAB8C7E32CE</gtr:id><gtr:title>Insitu thioester formation for protein ligation using a-methylcysteine</gtr:title><gtr:parentPublicationTitle>Chem. Sci.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c3ab27db6105264c6e5a887667c2adc"><gtr:id>9c3ab27db6105264c6e5a887667c2adc</gtr:id><gtr:otherNames>Burlina F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>545bbc4fe78e46.16758063</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDE7D3C8-35C0-46DB-9AC5-8DFE77C65D5F</gtr:id><gtr:title>Laser photolysis of DPNI-GABA, a tool for investigating the properties and distribution of GABA receptors and for silencing neurons in situ.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76b2edf9530517bb0cb949d73719cdb3"><gtr:id>76b2edf9530517bb0cb949d73719cdb3</gtr:id><gtr:otherNames>Trigo FF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0165-0270</gtr:issn><gtr:outcomeId>NLi5PUuLpA8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73BFC0F6-24D5-4B2E-88B5-2DA220891E33</gtr:id><gtr:title>Chemical labelling of active serum thioester proteins for quantification.</gtr:title><gtr:parentPublicationTitle>Immunobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1176be6a887517e5ef8cd01813499aad"><gtr:id>1176be6a887517e5ef8cd01813499aad</gtr:id><gtr:otherNames>Holm L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0171-2985</gtr:issn><gtr:outcomeId>A1XzG8x7eUF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D71A4B87-5514-4BD3-BCB4-8A68C51AEA4C</gtr:id><gtr:title>Evaluating the use of Apo-neocarzinostatin as a cell penetrating protein.</gtr:title><gtr:parentPublicationTitle>Protein engineering, design &amp; selection : PEDS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f65be00d6b1ceda2023c6297ec494126"><gtr:id>f65be00d6b1ceda2023c6297ec494126</gtr:id><gtr:otherNames>Moody P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1741-0126</gtr:issn><gtr:outcomeId>pm_14701_21_23322746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>799A04B7-889D-4F47-B04B-88605CF956E0</gtr:id><gtr:title>Native chemical ligation with Nalpha acyl transfer auxiliaries.</gtr:title><gtr:parentPublicationTitle>Biopolymers</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/62de2b44c37de108e158230767e9a5e1"><gtr:id>62de2b44c37de108e158230767e9a5e1</gtr:id><gtr:otherNames>Offer J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3525</gtr:issn><gtr:outcomeId>QhFD57aqVpW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A70625E-E4A7-40C5-AB83-98C8DB809488</gtr:id><gtr:title>Simplifying native chemical ligation with an N-acylsulfonamide linker.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c3ab27db6105264c6e5a887667c2adc"><gtr:id>9c3ab27db6105264c6e5a887667c2adc</gtr:id><gtr:otherNames>Burlina F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>pm_14701_21_22290414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E3D7CA0-B287-4601-A729-FAD5E28AFBCE</gtr:id><gtr:title>Synthesis and photolytic evaluation of a nitroindoline-caged glycine with a side chain of high negative charge for use in neuroscience</gtr:title><gtr:parentPublicationTitle>Tetrahedron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35f4831170772c8bb7a6b7690dac46c7"><gtr:id>35f4831170772c8bb7a6b7690dac46c7</gtr:id><gtr:otherNames>Papageorgiou G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>o9WjkNQusat</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2854C3C-AEF9-4252-B292-AAEC075E4F38</gtr:id><gtr:title>Jarid2 Methylation via the PRC2 Complex Regulates H3K27me3 Deposition during Cell Differentiation.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3eebe7ac7302c4af50784d3def7b59d2"><gtr:id>3eebe7ac7302c4af50784d3def7b59d2</gtr:id><gtr:otherNames>Sanulli S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>574efd9ab35914.42179523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8C6A06E-5F2E-42BD-A736-114DC6A80F65</gtr:id><gtr:title>A backbone amide protecting group for overcoming difficult sequences and suppressing aspartimide formation.</gtr:title><gtr:parentPublicationTitle>Journal of peptide science : an official publication of the European Peptide Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc3eaf4587e2cc3efe963aa0863929c4"><gtr:id>bc3eaf4587e2cc3efe963aa0863929c4</gtr:id><gtr:otherNames>Abdel-Aal AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1075-2617</gtr:issn><gtr:outcomeId>574efd9a5ca2d8.62096885</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U117592730</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>8EA3EC93-8E9C-482F-8121-C6C8413D9B6D</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.3  Chemical and physical sciences</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>